Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Delia Goletti

Showing results (261-270 of 310) with videos related to

Pageof 31
Sort By:
Vaccines|July 2, 2021
Impact of Prior Influenza and Pneumoccocal Vaccines on Humoral and Cellular Response to SARS-CoV-2 BNT162b2 VaccinationVincenzo Puro, Concetta Castilletti, Chiara Agrati, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 12, 2022
Identification of HLA-E Binding <i>Mycobacterium tuberculosis</i>-Derived Epitopes through Improved Prediction ModelsPaula Ruibal, Kees L M C Franken, Krista E van Meijgaarden, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|September 13, 2020
Association of baseline white blood cell counts with tuberculosis treatment outcome: a prospective multicentered cohort studyCarole Chedid, Eka Kokhreidze, Nestani Tukvadze, et al.
Scientific Reports|July 18, 2023
Identification of circulating monocytes as producers of tuberculosis disease biomarker C1qPaula Niewold, Douwe J Dijkstra, Yi Cai, et al.
Seminars in Arthritis and Rheumatism|November 27, 2015
Tailored first-line biologic therapy in patients with rheumatoid arthritis, spondyloarthritis, and psoriatic arthritisFabrizio Cantini, Laura Niccoli, Carlotta Nannini, et al.
Vaccines|October 28, 2023
Evaluation of Cross-Immunity to the Mpox Virus Due to Historic Smallpox VaccinationGiulia Matusali, Elisa Petruccioli, Eleonora Cimini, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 28, 2012
Janus-faced liposomes enhance antimicrobial innate immune response in Mycobacterium tuberculosis infectionEmanuela Greco, Gianluca Quintiliani, Marilina B Santucci, et al.
Scientific Reports|July 2, 2021
Multi-country evaluation of RISK6, a 6-gene blood transcriptomic signature, for tuberculosis diagnosis and treatment monitoringRim Bayaa, Mame Diarra Bousso Ndiaye, Carole Chedid, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|March 9, 2023
Impact of COVID-19 on diagnosis of tuberculosis, multidrug-resistant tuberculosis, and on mortality in 11 countries in Europe, Northern America, and Australia. A Global Tuberculosis Network studyJoanitah Nalunjogi, Sergio Mucching-Toscano, Jean Pierre Sibomana, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|December 15, 2022
Longitudinal characterisation of B and T-cell immune responses after the booster dose of COVID-19 mRNA-vaccine in people with multiple sclerosis using different disease-modifying therapiesAlessandra Aiello, Andrea Coppola, Serena Ruggieri, et al.
Pageof 31

Showing results (261-270 of 310) with videos related to

Sort By:
Pageof 31
Vaccines|July 2, 2021
Impact of Prior Influenza and Pneumoccocal Vaccines on Humoral and Cellular Response to SARS-CoV-2 BNT162b2 VaccinationVincenzo Puro, Concetta Castilletti, Chiara Agrati, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 12, 2022
Identification of HLA-E Binding <i>Mycobacterium tuberculosis</i>-Derived Epitopes through Improved Prediction ModelsPaula Ruibal, Kees L M C Franken, Krista E van Meijgaarden, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|September 13, 2020
Association of baseline white blood cell counts with tuberculosis treatment outcome: a prospective multicentered cohort studyCarole Chedid, Eka Kokhreidze, Nestani Tukvadze, et al.
Scientific Reports|July 18, 2023
Identification of circulating monocytes as producers of tuberculosis disease biomarker C1qPaula Niewold, Douwe J Dijkstra, Yi Cai, et al.
Seminars in Arthritis and Rheumatism|November 27, 2015
Tailored first-line biologic therapy in patients with rheumatoid arthritis, spondyloarthritis, and psoriatic arthritisFabrizio Cantini, Laura Niccoli, Carlotta Nannini, et al.
Vaccines|October 28, 2023
Evaluation of Cross-Immunity to the Mpox Virus Due to Historic Smallpox VaccinationGiulia Matusali, Elisa Petruccioli, Eleonora Cimini, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 28, 2012
Janus-faced liposomes enhance antimicrobial innate immune response in Mycobacterium tuberculosis infectionEmanuela Greco, Gianluca Quintiliani, Marilina B Santucci, et al.
Scientific Reports|July 2, 2021
Multi-country evaluation of RISK6, a 6-gene blood transcriptomic signature, for tuberculosis diagnosis and treatment monitoringRim Bayaa, Mame Diarra Bousso Ndiaye, Carole Chedid, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases|March 9, 2023
Impact of COVID-19 on diagnosis of tuberculosis, multidrug-resistant tuberculosis, and on mortality in 11 countries in Europe, Northern America, and Australia. A Global Tuberculosis Network studyJoanitah Nalunjogi, Sergio Mucching-Toscano, Jean Pierre Sibomana, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|December 15, 2022
Longitudinal characterisation of B and T-cell immune responses after the booster dose of COVID-19 mRNA-vaccine in people with multiple sclerosis using different disease-modifying therapiesAlessandra Aiello, Andrea Coppola, Serena Ruggieri, et al.
Pageof 31